| 李婷,吴浩,王靖伊,等.问题管理家对冠心病合并心理障碍病人的干预效果研究[J].安徽医药,2024,28(9):1836-1841. |
| 问题管理家对冠心病合并心理障碍病人的干预效果研究 |
| Intervention effect of problem management plus on coronary heart disease patients with psychological disorders |
| |
| DOI：10.3969/j.issn.1009-6469.2024.09.031 |
| 中文关键词: 冠心病 焦虑 抑郁 问题管理家 心理干预 心理障碍 临床随机对照 |
| 英文关键词: Coronary disease Anxiety Depression Problem manager plus Psychological interventions Psychological disor-ders Clinical randomised control |
| 基金项目: |
|
| 摘要点击次数: 503 |
| 全文下载次数: 302 |
| 中文摘要: |
| 目的探究问题管理家( PM+)对合并心理障碍的冠心病病人的治疗效果。方法选取 2022年 7—12月收住安徽医科大学第一附属医院东城院区心血管内科的合并有心理障碍的冠心病病人 80例。以广泛性焦虑量表( GAD-7)或病人健康问卷(PHQ-9)得分为依据，采用分层随机分配法，每 3分为 1层，层内利用随机数字表分配，最终将 80例合并有心理障碍的冠心病病人分为干预组( n=40)与对照组( n=40)。合并有抑郁症状的冠心病病人按随机数字表法分为抑郁干预组( n=20)与抑郁对照组(n=20)；合并有焦虑症状的冠心病病人按随机数字表法分为焦虑干预组( n=20)与焦虑对照组( n=20)。所有病人均接受了介入治疗或药物治疗，干预组的病人在此基础上接受 PM+干预 5次，每周 1次。收集所有病人的一般资料包括姓名、性别、受教育程度、婚姻状态、居住状态，比较采用 χ2检验。使用心理结果概况( PSYCHLOPS)、 GAD-7、PHQ-9量表评估病人的心理健康状态；使用世卫组织残疾评定方案 2.0(WHODAS 2.0)评估病人身体健康状态；比较采用 t检验。结果抑郁干预组干预后得分(4.800±2.526)分较基线得分( 9.650±2.907)分下降( t=14.49，P<0.05)；抑郁对照组自身前后得分差异无统计学意义( t=1.10，P>0.05)。焦虑干预组干预后得分( 3.800±1.704)分较基线得分( 8.350±1.814)分下降( t=14.21，P<0.05)；焦虑对照组自身前后得分差异无统计学意义( t=1.86，P>0.05)。结论 PM+可以减轻合并有心理障碍的冠心病病人的焦虑、抑郁情绪，加强病人的自我管理。 |
| 英文摘要: |
| Objective To investigate the efficacy of Problem Management Plus (PM+ ) in the treatment of coronary heart disease(CHD) patients with comorbid psychological disorders.Methods Eighty patients with CHD and comorbid psychological disorders whowere admitted to the Department of Cardiovascular Medicine, The First Affiliated Hospital of Anhui Medical University (DongchengCampus) from July to December 2022 were selected for the study. Based on the scores of the 7-item Generalised Anxiety Disorder As- sessment (GAD-7) or Patient Health Questionnaire-9 (PHQ-9), the stratified random allocation method was used, and every 3 scoreswere put into 1 layer, and the random number table was used within the layer. Finally, eighty patients with CHD with comorbid psycho-logical disorders were assigned into the intervention group (n=40) and the control group (n=40). Patients with CHD with comorbid de- pressive symptoms were randomly assigned into a depression intervention group (n=20) and a depression control group (n=20); patients with CHD with comorbid anxiety symptoms were randomly assigned into an anxiety intervention group (n=20) and an anxiety control group (n=20). All patients received either interventional or pharmacological treatment, and patients in the intervention group receivedPM+ intervention 5 times, every once a week. General information including name, gender, education, marital status, and residentialstatus was collected for all patients and comparisons were made using a chi-square test. Patients' mental health status was assessed us- ing the psychological outcome profiles (PSYCHLOPS), GAD-7, and PHQ-9 scales; physical health status was assessed using the WHODisability Assessment Schedule (WHODAS 2.0); comparisons were made using t-tests.Results The post-test score for the depression intervention group was lower than the baseline score [ (4.800±2.526) vs. (9.650±2.907); t=14.49, P<0.05]; the difference was not statisti- cally significant between pre-and post-scores in the depression control group (t=1.10, P>0.05). The post-test score of the anxiety inter- vention group was lower than the baseline score [(3.800±1.704) vs. (8.350±1.814); t=14.21, P<0.05]; the difference was not found be- tween pre-and post-scores in the anxiety control group (t=1.86, P>0.05).Conclusion PM+ can reduce anxiety and depression of CHD patients with comorbid psychological disorders and enhance their self-management. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|
